Position
Chief Financial Officer
Company
FibroBiologics
HoustonBiotechnologyHealth CareTherapeuticsDescription
FibroBiologics, Inc has announced the appointment of Jason D. Davis, CPA, as Chief Financial Officer, effective immediately. Mr Davis brings over 20 years of experience in corporate finance and will play a crucial role in the company's growth and clinical development efforts.
Quick answer
FibroBiologics Appoints Jason D. Davis as Chief Financial Officer (June 9, 2025). FibroBiologics is based in Houston, Texas, United States.
- Who is the new Chief Financial Officer at FibroBiologics?
- FibroBiologics named Jason D. Davis Chief Financial Officer, announced June 9, 2025.
- What did FibroBiologics announce on June 9, 2025?
- FibroBiologics, Inc has announced the appointment of Jason D. Davis, CPA, as Chief Financial Officer, effective immediately. Mr Davis brings over 20 years of experience in corporate finance and will play a crucial role in the company's growth and clinical development efforts.
- What does FibroBiologics do?
- FibroBiologics is a clinical-stage biotechnology company developing a pipeline of treatments and seeking potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials.
- Where is FibroBiologics based?
- FibroBiologics is based in Houston, Texas, United States.
- Which similar companies made leadership changes around the same time?
- RxMP Therapeutics (June 9, 2025), Abcuro (June 9, 2025), Beacon Therapeutics (June 9, 2025) and Cure Rare Disease (June 9, 2025) also announced leadership changes within 45 days of FibroBiologics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- RxMP Therapeutics Appoints Shawna Khouri as Chief Operating Officer (June 9, 2025)
- Abcuro Appoints Courtney Cupples as Chief Commercial Officer (June 9, 2025)
- Beacon Therapeutics Appoints Dr. Daniel Chung as Chief Medical Officer (June 9, 2025)
- Cure Rare Disease Appoints Keith Sutton as Chief Science Officer (June 9, 2025)
- Lyell Immunopharma Appoints David Shook as Chief Medical Officer and Mark Meltz as General Counsel (June 9, 2025)
- Vivex Biologics Appoints Jon E. Block as Chief Clinical Officer (June 10, 2025)
Who to call at FibroBiologics, and when
A new leader at FibroBiologics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day FibroBiologics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at FibroBiologics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at FibroBiologics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment FibroBiologics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
FibroBiologics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.